According to Future Market Insights research, during the projected period, the global portable MRI market is expected to grow at a CAGR of 6.7%. The market value is projected to increase from US$ 2.8 billion in 2023 to US$ 5.4 billion by 2033. The portable MRI market was valued at US$ 2.7 billion at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 6.1% in 2023.
Market Outlook-
Key Market Attributes
Market Size, 2022 | US$ 2.7 Billion |
---|---|
Market Size, 2023 | US$ 2.8 Billion |
Market Size, 2033 | US$ 5.4 Billion |
Value CAGR (2023 to 2033) | 6.7% |
The preferred method for spotting potential pathology in many clinical neurological applications is magnetic resonance imaging (MRI). The major magnetic field strengths have been increased, gradient hardware has been improved, radio frequency (RF) coil technology has advanced, and expedited acquisition techniques have been developed, however these gains in MRI technology have come at the expense of these factors.
Exquisite spatial resolution, sensitivity to numerous facets of tissue microstructure, and thorough mapping of tissue metabolites are only a few of these developments. Sadly, mobility has been sacrificed in order to advance hardware and technology.
The only places that can afford to use MRI technology are large urban hospitals or well-equipped research universities due to their increasing size, weight, and power requirements as a result of these technological advancements.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global portable MRI market recorded a historic CAGR of 5.5% in the last 5 years from 2017 to 2022. The market value for the global portable MRI market was around 32.3% of the overall US$ 8.3 billion of the global magnetic resonance imaging (MRI) market.
Semi Annual Market Update
Particular | Value CAGR |
---|---|
H1 | 5.44% (2022 to 2032) |
H2 | 7.94% (2022 to 2032) |
H1 | 5.46% (2023 to 2033) |
H2 | 7.96% (2023 to 2033) |
In order to facilitate quick and well-informed clinical decision-making, point-of-care diagnostics refers to the immediate availability of medical tests and imaging at the patient's site. By enabling real-time on-site imaging and eliminating the need for patient transportation to far-off imaging facilities, portable MRI equipment have transformed healthcare.
The need for faster and more practical patient treatment, particularly in emergency situations in remote or underserved areas, fuels this trend. Patient results are directly impacted by portable MRI's capacity to deliver timely and reliable diagnostic data, which enables medical personnel to quickly begin the proper treatments.
Likewise, using portable MRI scanners for point-of-care diagnostics lowers patient fear and boosts compliance, which is beneficial for young patients and those who have claustrophobia. The use of portable MRI for point-of-care diagnostics is increasing as healthcare systems place a higher priority on accessibility and efficiency, which is fueling market growth and innovation in mobile medical imaging technology.
The market for portable MRIs is expanding as a result of the increasing prevalence of chronic disorders, notably ailments like strokes. The need for prompt and precise diagnostic imaging to evaluate brain health and inform treatment choices is expanding as the number of strokes occurs.
Faster access to imaging services, particularly in emergency and critical care settings, is made possible by portable MRI machines. Their portability and small size enable quick deployment, facilitating immediate stroke patient assessment. This skill facilitates early intervention and individualized treatment strategies, improving patient outcomes. Therefore, the need to address the increased incidence of chronic disorders like strokes benefits the portable MRI market, placing these products as essential instruments for effective and efficient healthcare delivery
Cost and affordability pose a significant restraint on the portable MRI market growth. Developing advanced, compact MRI technology while maintaining competitive pricing can challenge manufacturers. Research, development, and manufacturing costs can result in higher product prices, limiting adoption, particularly in resource-constrained healthcare settings.
Balancing innovation with cost-effectiveness is crucial to overcome this obstacle and ensure widespread accessibility to portable MRI technology, addressing budgetary concerns and driving broader market acceptance.
Market Growth Outlook by Key Countries
Country | Value CAGR |
---|---|
United States | 6.1% |
Germany | 7.9% |
United Kingdom | 6.3% |
Japan | 6.9% |
China | 7.0% |
India | 6.7% |
The United States dominates the global market with 30.9% market share in 2022 and is projected to continue experiencing high growth throughout the forecast period.
With the launch of a low-field portable MRI (pMRI) device operating at 0.064 T, the portable MRI market in the United States has experienced a significant breakthrough. Neuroimaging capabilities have been revolutionized by this ground-breaking solution, which has been placed carefully beside the bedsides of intensive care patients.
The acquisition of crucial sequences like T1-weighted (T1W), T2-weighted (T2W), fluid-attenuated inversion recovery (FLAIR), and diffusion-weighted imaging (DWI) is made easier by the pMRI, which is comparable to typical high-field MRI scanners.
This portable MRI is unique due to its portability and built-in security. The low-field pMRI does not require specialist shielding or present dangers from neighboring ferromagnetic hospital equipment, in contrast to its high-field counterparts. It's crucial to remember that this method allays worries about ionizing radiation exposure that are frequently connected to fixed and mobile non-contrast CT (NCCT) imaging. Its user-friendliness, which eliminates the requirement for an in-house MRI technician to operate it, is a unique feature.
An important step toward affordable and secure neuroimaging at the point of care has been made with the arrival of low-field pMRI in the United States market.
China dominates the global market with 7.3% of the market share in 2022. Due to the rise of Cesarean scar pregnancy (CSP), the market for portable MRI scanners is expanding in China. For an appropriate diagnosis and treatment of this medical condition, detailed imaging is required.
Most women with CSP are asymptomatic, with the most frequent symptom being light vaginal bleeding occasionally accompanied by slight abdomen pain. Therefore, magnetic resonance imaging (MRI) and ultrasonography are the two main imaging tests used for diagnosis.
For examining CSP instances, portable MRI scanners provide a practical and effective alternative, enabling prompt interventions and lowering the hazards connected with conventional imaging techniques.
They are a crucial tool in addressing CSP due to their portability and sophisticated imaging capabilities, which also fuels demand within the Chinese healthcare system and encourages the adoption of portable MRI technologies for better patient care.
Germany holds about 6.8% share in the global market in 2022 and is projected to increase during the forecast period. The rising popularity of home healthcare is fueling the expansion of the portable MRI industry in Germany. Portable MRI scanners offer an essential diagnostic tool that may be simply delivered to the patient's house as medical services move more and more in-home.
This makes imaging and monitoring more effective, especially for people with chronic diseases or limited mobility. These devices' mobility and ease of use match the desire for complete home-based medical care, which encourages their use in the German healthcare system and spurs market expansion.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Market Growth Outlook by Key Products
Product | Value CAGR |
---|---|
Superconducting-magnet-based portable MRI | 6.8% |
Electromagnet-based portable MRI | 7.4% |
Permanent-magnet-based portable MRI | 6.1% |
Superconducting-magnet-based portable MRI within the type segment hold a revenue share of 39.7% in 2022, and the same trend is being followed over the forecasted period. Due to the enhanced image quality and diagnostic accuracy that derive from its ability to deliver higher magnetic field strengths make it the favored option for sophisticated and precise imaging applications, which accounts for its dominance in the portable MRI market.
Market Growth Outlook by Key Applications
Application | Value CAGR |
---|---|
Neurology | 7.2% |
Musculoskeletal | 6.1% |
Gastroenterology | 7.7% |
Others | 8.1% |
Neurology held a market share of 46.8% in 2022. Due to the urgent requirement for quick, high-quality imaging, neurology leads the portable MRI industry. Portable MRI units are very popular in this application area because they provide quick on-site scans that help with speedy neurological disorder diagnosis and treatment.
Market Growth Outlook by Key End Users
End User | Value CAGR |
---|---|
Hospitals | 6.1% |
Diagnostic Centers | 6.9% |
Ambulatory Surgery Centers | 7.6% |
Others | 8.3% |
Hospital segment dominates the end user segment holding 43.2% market share in 2022. Due to their demand for diverse diagnostic imaging, patient volume, and existing infrastructure, hospitals dominate the portable MRI industry. They want instant access to enhanced imaging and on-site mobility, which will increase adoption and give them market domination.
Strategic partnerships are a priority for leading portable MRI companies as they work to create new product lines and expand their global consumer base.
Similarly, recent developments related to companies in the portable MRI market have been tracked by the team at Future Market Insights, which are available in the full report.
Related Market Growth Outlook Scenario
Particulars | Value CAGR |
---|---|
Magnetic Resonance Imaging (MRI) Contrast Agents Market | 4.2% |
MRI-safe CRT Devices Market | 9.4% |
Portable Ultrasound Bladder Scanner Market | 5.9% |
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2017 to 2022 |
Market Analysis | US$ Million for Value, Units for Volume |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa |
Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa, and Northern Africa |
Key Market Segments Covered | Product, Application, End User and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Pricing | Available upon Request |
The global market is currently valued at around US$ 2.7 billion in 2022.
The global estimate for 2023 is around US$ 2.8 billion.
The global market is set to reach a valuation of around US$ 5.4 billion by the end of 2033.
Sales of the market are set to witness growth at a CAGR of 6.7% between 2023 and 2033.
Demand for the global market increased at a 5.5% CAGR from 2017 to 2022.
The United States, China, Japan, Germany, and United Kingdom account for most demand within the market, currently holding around 56.3% market share.
The United States accounts for around 30.9% share of the global market in 2022.
China accounts for around 7.3% share of the global market in 2022.
The Germany market held a share of about 23.1% in the European market in 2022.
Superconducting-magnet-based portable MRI segment held 39.7% share of the global market in 2022.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation/Development Trends
4. Value Added Insights
4.1. Adoption Rate for Portable MRI
4.2. Regulatory Landscape
4.3. PESTLE Analysis
4.4. Porter's Analysis
4.5. Recent Product Approvals/Launches
4.6. Supply Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Global Parent Market Analysis (MRI Market)
5.1.3. Global Research and Development Funding by Region
5.2. Forecast Factors - Relevance and Impact
5.2.1. Increasing Prevalence of Chronic Disease
5.2.2. Top Companies’ Historical Growth
5.2.3. Diagnostics-Based Cost
5.2.4. Strategic Collaboration and Partnership
5.2.5. Growing Investment in Medical Devices
5.2.6. Technological Development
5.2.7. Increased Research and Development
5.2.8. Increasing Adoption Rate of Portable MRI
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Volume) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Volume (Units) Analysis, 2017 to 2022
6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033
6.3. Y-o-Y Growth Trend Analysis
7. Global Market – Pricing Assessment
7.1. Regional Pricing Analysis
7.2. Pricing Break-up
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033
8.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
8.2. Historical Market Value (US$ Million) Analysis, 2017 to 2022
8.3. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.3.1. Y-o-Y Growth Trend Analysis
8.3.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Product, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2023 to 2033
9.3.1. Superconducting-magnet-based portable MRI
9.3.2. Electromagnet-based portable MRI
9.3.3. Permanent-magnet-based portable MRI
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis by Application, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2023 to 2033
10.3.1. Neurology
10.3.2. Musculoskeletal
10.3.3. Gastroenterology
10.3.4. Others
10.4. Market Attractiveness Analysis by Application
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis by End User, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033
11.3.1. Hospitals
11.3.2. Diagnostic Centers
11.3.3. Ambulatory Surgery Centers
11.3.4. Others
11.4. Market Attractiveness Analysis by End User
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis by Region, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa
12.4. Market Attractiveness Analysis by Region
13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. United States
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Application
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis and Forecast
13.8.1. United States Market
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Application
13.8.1.2.3. By End User
13.8.2. Canada Market
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Application
13.8.2.2.3. By End User
14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis and Forecast
14.8.1. Brazil Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Application
14.8.1.2.3. By End User
14.8.2. Mexico Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Application
14.8.2.2.3. By End User
14.8.3. Argentina Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Application
14.8.3.2.3. By End User
15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. France
15.3.1.3. Spain
15.3.1.4. Italy
15.3.1.5. BENELUX
15.3.1.6. United Kingdom
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis and Forecast
15.8.1. Germany Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.1.2.3. By End User
15.8.2. France Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application
15.8.2.2.3. By End User
15.8.3. Spain Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Application
15.8.3.2.3. By End User
15.8.4. Italy Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Application
15.8.4.2.3. By End User
15.8.5. BENELUX Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Product
15.8.5.2.2. By Application
15.8.5.2.3. By End User
15.8.6. United Kingdom Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Product
15.8.6.2.2. By Application
15.8.6.2.3. By End User
15.8.7. Russia Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Product
15.8.7.2.2. By Application
15.8.7.2.3. By End User
16. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis and Forecast
16.8.1. China Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. Japan Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
16.8.2.2.3. By End User
16.8.3. South Korea Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Application
16.8.3.2.3. By End User
17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Thailand
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis and Forecast
17.8.1. India Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application
17.8.1.2.3. By End User
17.8.2. Indonesia Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application
17.8.2.2.3. By End User
17.8.3. Thailand Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Application
17.8.3.2.3. By End User
17.8.4. Malaysia Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Application
17.8.4.2.3. By End User
18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis and Forecast
18.8.1. Australia Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Application
18.8.1.2.3. By End User
18.8.2. New Zealand Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Application
18.8.2.2.3. By End User
19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. Northern Africa
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application
19.4.4. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis and Forecast
19.8.1. GCC Countries Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Application
19.8.1.2.3. By End User
19.8.2. Türkiye Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Application
19.8.2.2.3. By End User
19.8.3. Northern Africa Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Application
19.8.3.2.3. By End User
19.8.4. South Africa Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By Application
19.8.4.2.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
20.3.1. Regional footprint of Players
20.3.2. Product footprint by Players
20.3.3. Channel footprint by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Canon Medical Systems Corporation
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Key Financials
21.3.1.4. Sales Footprint
21.3.1.5. SWOT Analysis
21.3.1.6. Key Developments
21.3.1.7. Strategy Overview
21.3.1.7.1. Channel Strategy
21.3.1.7.2. Marketing Strategy
21.3.1.7.3. Product Strategy
21.3.2. GE Healthcare
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Key Financials
21.3.2.4. Sales Footprint
21.3.2.5. SWOT Analysis
21.3.2.6. Key Developments
21.3.2.7. Strategy Overview
21.3.2.7.1. Channel Strategy
21.3.2.7.2. Marketing Strategy
21.3.2.7.3. Product Strategy
21.3.3. Siemens Healthineers
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Key Financials
21.3.3.4. Sales Footprint
21.3.3.5. SWOT Analysis
21.3.3.6. Key Developments
21.3.3.7. Strategy Overview
21.3.3.7.1. Channel Strategy
21.3.3.7.2. Marketing Strategy
21.3.3.7.3. Product Strategy
21.3.4. Philips Healthcare
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Key Financials
21.3.4.4. Sales Footprint
21.3.4.5. SWOT Analysis
21.3.4.6. Key Developments
21.3.4.7. Strategy Overview
21.3.4.7.1. Channel Strategy
21.3.4.7.2. Marketing Strategy
21.3.4.7.3. Product Strategy
21.3.5. Hyperfine
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Key Financials
21.3.5.4. Sales Footprint
21.3.5.5. SWOT Analysis
21.3.5.6. Key Developments
21.3.5.7. Strategy Overview
21.3.5.7.1. Channel Strategy
21.3.5.7.2. Marketing Strategy
21.3.5.7.3. Product Strategy
21.3.6. Voxelgrids
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Key Financials
21.3.6.4. Sales Footprint
21.3.6.5. SWOT Analysis
21.3.6.6. Key Developments
21.3.6.7. Strategy Overview
21.3.6.7.1. Channel Strategy
21.3.6.7.2. Marketing Strategy
21.3.6.7.3. Product Strategy
21.3.7. PrizMed Imaging
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Key Financials
21.3.7.4. Sales Footprint
21.3.7.5. SWOT Analysis
21.3.7.6. Key Developments
21.3.7.7. Strategy Overview
21.3.7.7.1. Channel Strategy
21.3.7.7.2. Marketing Strategy
21.3.7.7.3. Product Strategy
21.3.8. Koninklijke Philips N.V.
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Key Financials
21.3.8.4. Sales Footprint
21.3.8.5. SWOT Analysis
21.3.8.6. Key Developments
21.3.8.7. Strategy Overview
21.3.8.7.1. Channel Strategy
21.3.8.7.2. Marketing Strategy
21.3.8.7.3. Product Strategy
21.3.9. Hitachi Ltd
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Key Financials
21.3.9.4. Sales Footprint
21.3.9.5. SWOT Analysis
21.3.9.6. Key Developments
21.3.9.7. Strategy Overview
21.3.9.7.1. Channel Strategy
21.3.9.7.2. Marketing Strategy
21.3.9.7.3. Product Strategy
21.3.10. Mitsubishi Electric
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Key Financials
21.3.10.4. Sales Footprint
21.3.10.5. SWOT Analysis
21.3.10.6. Key Developments
21.3.10.7. Strategy Overview
21.3.10.7.1. Channel Strategy
21.3.10.7.2. Marketing Strategy
21.3.10.7.3. Product Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports